Technology Review Djibouti : Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology Review Djibouti .

Press releases published on September 8, 2026

12 hours ago

Quantum Cyber Acquires NVIDIA A100 AI Compute Cluster to Power Its Swarm Operating System

Indeterminate GlobeNewswire

12 hours ago

Cognition Therapeutics to Present at H.C. Wainwright Global Investment Conference

Indeterminate GlobeNewswire

12 hours ago

CervoMed to Participate in September Investor Conferences

Indeterminate GlobeNewswire

12 hours ago

SalesCloser Enters Collaboration Agreement with Tendril to Combine Autonomous AI Engagement and Human-Assisted Outbound Dialing

Indeterminate GlobeNewswire

12 hours ago

Nasus Pharma to Participate in the H.C. Wainwright 28th Annual Global Investment Conference

Indeterminate GlobeNewswire

12 hours ago

BioVie Announces Update to Parkinson’s Phase 3 Development Program

Indeterminate GlobeNewswire

12 hours ago

OptimizeRx to Participate in the 10th Annual Lake Street Best Ideas Growth Conference

Indeterminate GlobeNewswire

12 hours ago

BriaCell’s Pivotal Phase 3 Metastatic Breast Cancer Study Expands to Leading Cancer Center

Indeterminate GlobeNewswire

12 hours ago

BrainsWay Reports Promising Pilot Study Results in Patients with Depression and Comorbid Early-Stage Alzheimer’s Disease Treated with Deep TMS™

Indeterminate GlobeNewswire

12 hours ago

Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board

Indeterminate GlobeNewswire

12 hours ago

Artiva Biotherapeutics Provides Update on Planned AlloNK® Data Disclosures and Development Milestones for the Remainder of 2026

Indeterminate GlobeNewswire

12 hours ago

Medicus Pharma Advances Transformation into a Precision Oncology-Led Biotechnology Company

Indeterminate GlobeNewswire

12 hours ago

SPIRIT BLOCKCHAIN CAPITAL ANNOUNCES NAME CHANGE TO IMPAUER TECHNOLOGIES INC. AND NEW TRADING SYMBOLS

Indeterminate GlobeNewswire

12 hours ago

ContentCon 2026: Every Brand Now Has Two Audiences, Humans and Agents

Indeterminate GlobeNewswire

13 hours ago

Generate Biomedicines Inc. to Participate in September Investor Conferences

Indeterminate GlobeNewswire

13 hours ago

Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event

Indeterminate GlobeNewswire

13 hours ago

Lantronix CEO to Participate in Upcoming Investor and Industry Events

Indeterminate GlobeNewswire

13 hours ago

Microchip’s 1.2V Clock Buffers Link Latest SoCs and FPGAs with Higher Voltage Components

Indeterminate GlobeNewswire

13 hours ago

Invivyd to Participate in Upcoming September Investor Conferences

Indeterminate GlobeNewswire

13 hours ago

Infex Therapeutics presents new Phase IIa data for RESP-X at ERS Congress 2026, providing further evidence on exploratory efficacy endpoints supporting progression to later stage development

Indeterminate GlobeNewswire